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Background: Antibiotics are some of the most commonly prescribed drugs in the Emergency Department (ED)
and yet data describing the overall appropriateness of antibiotic prescribing in the ED is scarce.
Objectives: To describe the appropriateness of antibiotic prescribing in the ED.
Methods: A retrospective, observational study of current practice. All patients who presented to the ED during
the study period and were prescribed at least one antibiotic were included. Specialists from Infectious Disease,
Microbiology and Emergency Medicine and a Senior Pharmacist assessed antibiotic appropriateness against
evidence-based guidelines.
Results: A total of 1019 (13.6%) of patient presentations involved the prescription of at least one antibiotic. Of
these, 640 (62.8%) antibiotic prescriptions were assessed as appropriate, 333 (32.7%) were assessed as inappro-
priate and 46 (4.5%) were deemed to be not assessable. Adults were more likely to receive an inappropriate anti-
biotic prescription than children (36.9% versus 22.9%; difference 14.1%, 95% CI 7.2%–21.0%). Patients who met
quick Sepsis-related Organ Failure Assessment (qSOFA) criteria were more likely to be prescribed inappropriate
antibiotics (56.7% versus 36.1%; difference 20.5%, 95% CI, 2.4%–38.7%). There was no difference in the inci-
dence of appropriate antibiotic prescribing based on patient gender, disposition (admitted/discharged), reason
for antibiotic administration (treatment/prophylaxis) or time of shift (day/night).
Conclusions: Inappropriate administration of antibiotics can lead to unnecessary adverse events, treatment
failure and antimicrobial resistance. With over one in three antibiotic prescriptions in the ED being assessed as in-
appropriate, there is a pressing need to develop initiatives to improve antibiotic prescribing to prevent antibiotic-
associated patient and community harms.
Introduction
The timely administration of appropriate antibiotics in the
Emergency Department (ED) can be lifesaving.1 However, antibiot-
ics are not a benign intervention and unnecessary or inappropriate
antibiotics can lead to patient and community harms, including
the harms associated with adverse events, treatment failure and
antimicrobial resistance (AMR).2,3 A recent study by Tamma et al.2
found that among patients to whom antibiotics were administered
in hospital, one in five experienced a clinically significant antibiotic-
associated adverse drug event.
The ED is an important setting for addressing inappropriate
antibiotic prescribing practices, given that it sits at the interface of
the community and the hospital.4 The ED is also unique in its chal-
lenges to appropriate antibiotic prescribing, with ED-based clini-
cians frequently faced with the combination of both diagnostic
uncertainty and time pressure.5 However, despite this, antimicro-
bial stewardship (AMS) initiatives are rarely tailored to the ED6 and
data describing the overall incidence of inappropriate prescribing
in the ED to inspire such initiatives are scarce.
We therefore aimed to describe the overall incidence of anti-
biotic prescribing in a busy, tertiary-level academic ED. Further, the
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appropriateness of antibiotic prescriptions was judged against
evidence-based guidelines or, in cases in which endorsed guide-
lines were not available or applicable, by expert opinion using a
previously validated antibiotic appropriateness assessment tool.
We additionally assessed antibiotic appropriateness for pre-
defined subgroups based on age, gender, indication for antibiotics
(treatment versus prophylaxis) and whether the patient met the
criteria for sepsis.
Patients and methods
Design, setting and population
The study was conducted at a large, public tertiary ED in Queensland,
Australia with on-site microbiology and infectious disease specialists. The
census in 2016 was 102 286 ED attendances, of which 24.4% were paediat-
ric. The institutional Human Research Ethics Committee approved the study
(HREC/17/QGC/41), including a waiver for informed consent owing to the
observational nature of the study. Findings are reported in accordance with
the Strengthening the Reporting of Observational studies in Epidemiology
(STROBE) Statement for cohort studies.7
All consecutive patients who presented to the ED over a total period of
4 weeks throughout 2016 (1–7 February; 9–15 May; 22–28 August; 14–20
November) were included. These four weeks were selected prior to data ex-
traction to avoid potential time-of-year-dependent confounders, including
seasonal variation and holiday periods.
Data collection
Clinical information of all patients who presented to the ED during the des-
ignated study period was reviewed. The electronic Emergency Department
Information System was used to identify patients who presented to the ED
during the study period. The electronic medical record (EMR) was then
reviewed for all patients. For those patients who had an antibiotic pre-
scribed either in the ED or on discharge from the ED, data were extracted
from both the EMR and the laboratory information system, AUSLAB, and
entered into a pre-formatted database.
Data included patient demographics, comorbidities, indication for anti-
biotics, type/dose/route of antibiotic(s) prescribed, clinical observations and
results of blood tests and cultures. Additional information was collected
regarding: patient disposition (discharge home, ED admission, hospital
ward admission, ICU admission or death in the ED); hospital length-of-stay;
whether infectious disease or microbiology expert advice was sought whilst
the patient was in the ED; whether the patient had antibiotics in the 24 h
prior to their ED visit; time of antibiotic administration (day shift: 07:30–
23:29; night shift: 23:30–07:29); or any known allergy to an antibiotic. If a
reason for deviation from antibiotic prescribing guidelines was given (e.g.
prior culture and susceptibility results, significant wound contamination)
this was also noted. Patients receiving topical antibiotic, antifungal or anti-
viral medication only were excluded. Four patients were prescribed antiviral
medication only during the study period.
The presumed indication for antibiotic prescribing was taken from the
treating clinician’s working diagnosis as documented in the medical record.
Indications were then grouped into two main categories: (i) treatment of
presumed infection; or (ii) prophylaxis. Treatment of presumed infection
was then further categorized based on the site of presumed infection: ab-
dominal (e.g. diverticulitis, appendicitis); CNS (e.g. meningitis); dental (e.g.
dental abscess); ear/nose/throat (e.g. otitis media, tonsillitis); gynaecologic-
al (e.g. pelvic inflammatory disease); orthopaedic (e.g. osteomyelitis); re-
spiratory (e.g. pneumonia); skin (e.g. cellulitis, skin abscess); urinary
(e.g. cystitis, pyelonephritis); unknown source; or other (i.e. not fitting into
aforementioned categories). Prophylaxis was further categorized into:
bite prophylaxis; surgical prophylaxis; wound prophylaxis; or other (i.e. not
fitting into aforementioned categories). When the medical record was
incomplete or unavailable or the indication for antibiotics was unclear, the
label of ‘unknown indication’ was applied.
Derived variables included Systemic Inflammatory Response Syndrome
(SIRS) and quick Sepsis-related Organ Failure Assessment (qSOFA) scores.
These scores have been proposed as tools to assist in the identification of
patients with infection and identification of those who are at a greater risk
of a poor outcome, respectively.8,9 Patients over the age of 18 years met
SIRS criteria if they had two or more of: temperature38C or,36C; heart
rate .90 beats/min; respiratory rate .20 breaths/min; or white blood cell
count .12%109/L or ,4%109/L. Patients over the age of 18 years met
qSOFA criteria if they had two or more of: Glasgow Coma Scale,15; respira-
tory rate .22 breaths/min; or systolic blood pressure ,100 mmHg. Missing
data were handled by assuming the patient did not meet the criteria. There
is no current qSOFA equivalent in paediatrics and the use of SIRS criteria in
the paediatric population is not based on evidence related to clinical out-
comes.10 The paediatric subpopulation was therefore excluded from calcu-
lations of these derived variables.
Assessment of antibiotic appropriateness
Antibiotic appropriateness was assessed by a panel of four experts from the
fields of Emergency Medicine, Infectious Disease, Microbiology and a Senior
AMS Pharmacist. The experts utilized evidence-based guidelines together
with a pre-established antibiotic appropriateness assessment tool, the
National Antibiotic Prescribing Survey (NAPS) table (see Table S1, available
as Supplementary data at JAC Online).11,12 This tool has been developed
using published methods,13 in which a high rate of inter-rater reliability and
high validity was achieved between assessors of varying experience with
antimicrobial prescribing. The validity of this approach has been further
demonstrated by the consistency of findings from nationwide hospital
point-prevalence studies.14 Notably, each expert was given only data that
would have been available to the ED-based prescriber at the time of anti-
biotic decision-making (i.e. no culture/susceptibility results were provided).
All patient presentations wherein at least one antibiotic was prescribed
were randomized and each assigned to two experts. Each expert then
independently assessed the antibiotic prescription as being optimal (1),
adequate (2), suboptimal (3), inadequate (4) or not assessable (5) as per
NAPS guidelines.12 If there was no agreement between the two expert
assessors—wherein disagreement was defined as two assessors assign-
ing a different score, except when assessors scored a (1) and a (2)—then
the case was discussed between all four experts at a round-table discus-
sion. Seven cases required round-table discussion. If an antibiotic regimen
was discussed with an infectious disease or microbiology team at the time
of prescribing, an assessment of optimal (1) was automatically given.
Reasons for an assessment of inappropriate (3 or 4) were also recorded.
Data analysis and sample size
To determine proportions (including appropriateness of prescription) with a
95% certainty and a two-sided error of 1.8% we calculated that we required
a total of 1333 patients who were prescribed antibiotics. Based on an
expected prescription rate of 16.5% we required 7500 patients, which
equated to 4 weeks of patient presentations. IBM SPSS v24 and Open
Source Epidemiologic Statistics for Public Health v3.01 (OpenEpi) were
employed to perform descriptive and inferential statistics. For the majority
of analyses, NAPS scores were grouped as either appropriate (i.e. NAPS
score of 1 or 2) or inappropriate (i.e. NAPS score of 3 or 4). Patient presenta-
tions that were assessed as not assessable (5) were excluded.
Relationships between categorical variables were assessed using a v2 test
or Fisher’s exact test (where appropriate). The Wilson score interval method
was used to calculate 95% CI for proportions, corrected for population size.
ORs comparing factors associated with appropriate versus inappropriate
prescribing were calculated using the mid-P exact conditional maximum
likelihood estimate of the OR.
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Results
During the study period, a total of 7497 patients presented to the
ED. One thousand and nineteen (13.6%; 95% CI 12.8%–14.4%)
patients were prescribed at least one antibiotic. Only five (0.5%)
patients were discussed with an on-call infectious disease or
microbiology clinician. Of patients over 18 years who were pre-
scribed antibiotics for treatment of presumed infection—i.e.
excluding those under 18 years of age and those who were pre-
scribed antibiotics for prophylaxis—29.5% (200/678) met SIRS cri-
teria and 4.7% (32/678) met qSOFA criteria for sepsis.
Characteristics of patients who were prescribed antibiotics are
described in Table 1.
The majority (n"843; 82.7%) of presentations involving an
antibiotic prescription were administered with the intention of
treating infection and 171 (16.7%) were administered for prophy-
laxis. For five patients (0.5%) the indication for antibiotics was un-
clear from the clinician notes. Infections of the skin (20.5%) were
the most common indication for prescribing antibiotics, followed
by respiratory tract infections (15.7%), urinary tract infections
(15.6%) and antibiotic prophylaxis for wounds (11.6%). Of antibiot-
ics administered in the ED, 74.0% were given intravenously, 25.5%
were given via the oral route and 0.5% were given intramuscularly.
Types of antibiotics prescribed are also detailed (see Table S2).
Of the 1019 patient presentations for which at least one anti-
biotic was prescribed, 640 (62.8%) were assessed to be optimal or
adequate, 152 (14.9%) were assessed to be suboptimal, 181
(17.8%) were assessed to be inadequate and 46 (4.5%) were
deemed to be not assessable. Thus, when categorized as a bino-
mial of either appropriate (i.e. optimal or adequate) or inappropri-
ate (suboptimal or inadequate), 65.8% (640/973) were assessed
as appropriate (95% CI 62.8%–68.7%) and 34.2% (333/973) were
assessed as inappropriate (95% CI 31.3%–37.3%). The most com-
mon reason given for an assessment of suboptimal was the anti-
biotic regimen was too broad and/or there was unnecessary
overlap of spectrum (67.8%; 103/152). The most common reason
given for an assessment of inadequate was that antibiotics were
not required at all (53.6%; 97/181) for the indication provided.
Paediatric patients were more likely to have been prescribed an
appropriate antibiotic than adult patients (77.1% versus 63.1%;
difference 14.1%; 95% CI 7.2%–21.0%). Of the 678 adult patients
eligible for calculation of SIRS and qSOFA scores, 650 (95.9%) were
able to be assessed for antibiotic appropriateness. Patients who
met qSOFA criteria for sepsis were less likely to be prescribed an ap-
propriate antibiotic than patients who did not (43.3% versus
63.9%; difference 20.5%; 95% CI 2.4%–38.7%). There were no sig-
nificant differences in the incidence of appropriate antibiotic pre-
scribing between patients who did and did not meet SIRS criteria
(68.4% versus 61.5%; difference 6.9%; 95% CI#1.0% to 14.8%) or
patients prescribed antibiotics for treatment of presumed infection
and those prescribed antibiotics for prophylaxis (66.6% versus
61.5%; difference 5.1%; 95% CI #3.1% to 13.3%). Further, there
were no significant differences in the incidence of appropriate pre-
scribing based on gender, patient disposition, triage category or
time of shift (day/night). Table 2 describes characteristics of
patients prescribed both appropriate and inappropriate antibiotics.
Table 3 details the site and assessment of appropriateness for
both treatment and prophylactic antibiotic regimens.
Discussion
This study provides important insights into the current practice of
antibiotic prescribing in the ED. Our data are unique in that they
examine the characteristics of all consecutive patients who were
prescribed an antibiotic, rather than limiting data collection to a
specific disease condition. This has several benefits, including the
overall identification of how frequently antibiotics are prescribed in
the ED and the most common conditions for which antibiotics are
prescribed; it additionally enables an overall assessment of the ap-
propriateness of ED-based antibiotic prescribing.
The appropriateness of antibiotic prescriptions was judged only
on the presumed diagnosis from the EMR and clinical observa-
tions/investigations available to the doctor at the time of prescrib-
ing in the ED. This method allowed for a practical, ‘real-world’
Table 1. Characteristics of patients to whom antibiotics were prescribed
in the ED
Patient characteristics
Total number of patient presentations seen in
ED during study period
7497
Total patient presentations involving antibiotics, n (%) 1019 (13.6)
Total number of antibiotics prescribed 1670
Age, years, mean (SD) 41.3 (+25.4)
Gender, n (%)
male 527 (51.7)
female 492 (48.3)
Antibiotics ,24 h prior to ED presentation, n (%)
yes 201 (19.7)
no 818 (80.3)
Documented antibiotic ADR, n (%)
yes 126 (12.4)
no 893 (87.6)
Disposition, n (%)
discharged home from ED 324 (31.8)
ED short-stay unit 204 (20.0)
admitted to hospital ward 472 (46.3)
operating theatre 9 (0.9)
admitted to ICU 10 (1.0)
Patients prescribed antibiotic(s), n (%)
in the ED+discharge script 778 (76.3)
on discharge script only 241 (23.7)
Discussed with infectious disease or
microbiology team, n (%)
yes 5 (0.5)
no 1014 (99.5)
SIRS criteria meta? n/N (%)
yes 200/678 (29.5)
no 478/678 (70.5)
qSOFA criteria meta? n/N (%)
yes 32/678 (4.7)
no 646/678 (95.3)
ADR, adverse drug reaction.
aSIRS and qSOFA criteria were only applied to patients over the age of
18 years who were prescribed antibiotics to treat presumed infection.
Appropriate antibiotics in the emergency department JAC
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approach to the adjudication of antibiotic prescribing in the ED.
This contrasts with many previous studies assessing antibiotic ap-
propriateness, where appropriateness has been defined based on
culture and susceptibility results.15–18 Culture results are often
both (i) unavailable to the ED clinician at the time of antibiotic pre-
scribing and (ii) often confounded by both false positives (e.g. con-
tamination and colonization) and false negatives.19–21 Culture and
susceptibility test results are often particularly unhelpful (i.e. not
required) in patients who are not systemically unwell with their in-
fection19,20,22–24 and thus a retrospective, culture-based method
of assessing antibiotic appropriateness is unsuitable for many pa-
tient presentations included in our study.
Antibiotics were found to be a common intervention in the ED,
with more than 1 in 8 patient presentations involving the prescrib-
ing of one or more antibiotic(s). This study demonstrated that the
majority of antibiotics were prescribed to patients who did not
meet established criteria (SIRS/qSOFA) for sepsis. There is a prom-
inent research emphasis dedicated to identifying sepsis in the ED
with a focus on targeting early initiation of antibiotics.25 In septic
shock, delays in antibiotic administration in the ED have been asso-
ciated with increased mortality,26–28 increasing the pressure on
clinicians to make early decisions when prescribing antibiotics.
However, we hypothesize that the larger cohort of less-sick ED
patients (i.e. not meeting any sepsis criteria) who are prescribed
antibiotics represents fertile ground for identifying areas more eas-
ily amenable to AMS or identifying conditions wherein antibiotics
may not be required at all. For example, strong evidence already
exists that antibiotics are not required for uncomplicated otitis
media,29 uncomplicated diverticulitis,30 acute bronchitis,31 domes-
tic animal bite prophylaxis32 and simple hand lacerations.33
The administration of inappropriate antibiotics in the ED was com-
mon, with 1 in 3 patients being prescribed an antibiotic regimen
that was assessed as either suboptimal or inadequate. The most
common reasons that assessors deemed an antibiotic prescription
to be inappropriate were that antibiotics were either too broad, there
was an unnecessary overlap of spectrum or antibiotics were not
required at all. Such overprescribing increases the risk of unnecessary
antibiotic-associated adverse events, opportunistic infections [e.g.
Clostridioides (Clostridium) difficile infection] and AMR.2,3 We there-
fore propose the need for AMS regimens tailored to the ED environ-
ment to reduce unnecessary antibiotic exposure. This is particularly
important given that the majority of antibiotic regimens prescribed in
the ED continue unchanged by inpatient teams after 48 h.34 It thus
follows that antibiotic prescribing in the ED impacts the patterns of
antibiotic use across the hospital. Possible AMS strategies include:
increasing the presence of ED-based clinical pharmacists; adopting
electronic prescribing systems that incorporate clinical decision sup-
port tools; and ED-specific antibiogram development.4,35
Table 2. Patient/prescription characteristics and appropriateness
Characteristic Appropriate, n/N (%) Inappropriate, n/N (%)
Percentage difference for inappropriate
prescribing (95% CI)
Age, years
,18 145/188 (77.1) 43/188 (22.9) 14.1% (7.2–21.0)
18 495/785 (63.1) 290/785 (36.9)
Gender
female 316/474 (66.7) 158/474 (33.3) 1.7% (#4.2–7.7)
male 324/499 (64.9) 175/499 (35.1)
Patient disposition
discharged 203/306 (66.3) 103/306 (33.7) 0.8% (#5.6–7.2)
admitted 437/667 (65.5) 230/667 (34.5)
Triage category
1 23/42 (54.8) 19/42 (45.2) 11.2% (#5.3–27.7)
2 108/167 (64.7) 59/167 (35.3) 1.3% (#8.6–11.2)
3 385/576 (66.8) 191/576 (33.2) 0.9% (#6.9–8.7)
4/5 124/188 (66.0) 64/188 (34.0) (reference)
SIRS criteria meta?
yes 134/196 (68.4) 62/196 (31.6) 6.9% (#1.0–14.8)
no 279/454 (61.5) 175/454 (38.5)
qSOFA criteria meta?
yes 13/30 (43.3) 17/30 (56.7) 20.5% (2.4–38.7)
no 396/620 (63.9) 224/620 (36.1)
Reason for antibiotic administration
treatment 541/812 (66.6) 271/812 (33.4) 5.1% (#3.1–13.3)
prophylaxis 99/161 (61.5) 62/161 (38.5)
Time that antibiotic was prescribed
day shift 374/559 (66.9) 185/559 (33.1) 0.6% (#7.3–8.5)
night shift 120/181 (66.3) 61/181 (33.7)
Values in bold indicate statistical significance.
aSIRS and qSOFA criteria were only applied to patients over the age of 18 years who were prescribed antibiotics to treat presumed infection.
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We also investigated antibiotic appropriateness for pre-defined
subgroups of patients. Patients who met qSOFA criteria for sepsis
were more likely to be prescribed inappropriate antibiotics than
those who did not meet qSOFA criteria. We hypothesize that, for
these sicker patients, clinicians are under greater time pressures to
administer antibiotics and, consequently, the haste to administer
antibiotics may drive inappropriate prescribing. Further research,
however, is required to see whether this finding can be replicated
and, if so, determine whether an association between time-to-
antibiotics and appropriateness of antibiotics exists. The lack of an
association between meeting SIRS criteria and antibiotic appropri-
ateness, on the other hand, is unsurprising given that SIRS is a
poorer marker of critical illness compared with qSOFA.36
Finally, we found that adult patients were significantly more
likely to have been prescribed inappropriate antibiotics than chil-
dren. The reasons for this are unclear and require further explor-
ation. Possible hypotheses may include that antibiotic prescribing
decisions in children are simpler owing to fewer comorbidities or,
alternatively, there may be an increased reluctance to prescribe
medications to this population.
Limitations
This study suffers from the inherent limitations of retrospective
design and thus is suited more towards hypothesis generation,
rather than determining causal factors that influence the ap-
propriateness of antibiotic prescribing. The single-centre nature
of the study may also limit its generalizability. Nonetheless, by
using a large number of consecutive patients with few missing
data for key variables, this study provides a solid platform for fu-
ture, multi-centre prospective studies that can replicate our
methods. Although we included fewer patients than intended
(1019 versus 1333), this did not affect the magnitude of the
sample error (2.0% versus 1.8%).
Further, the assessment of antibiotic appropriateness based on
data available at the time of ED presentation has the potential to
be influenced by inter-assessor variability. We have attempted to
minimize this via both (i) defining appropriateness based on a pre-
viously established tool designed for this purpose that relies on
evidence-based guidelines, and (ii) using a panel of specialists
from relevant but diverse backgrounds. We believe that the thor-
oughness and practical approach to our assessment of appropri-
ateness is a unique strength of this study, which we have detailed
in the methodology so that it may be replicated by other investiga-
tors. Finally, the present study was purely descriptive in nature and
as such we did not aim to quantify what constitutes a clinically
relevant difference in proportions of appropriate antibiotic pre-
scribing, since this is likely to be setting-, condition- and patient-
specific. However, we hypothesize that even small improvements
in appropriate prescribing are likely to lead to relevant patient and
health economic outcomes.
In conclusion, our study provides contemporaneous insights
into the practice of antibiotic prescribing in the uniquely
challenging environment of the ED. Antibiotics were found to
be a common intervention in the ED and, with over one in
three antibiotic prescriptions being assessed as inappropriate,
there is a pressing need to develop initiatives to improve ED-
based antibiotic prescribing. We propose the need for
future studies that aim to further explore and address factors
associated with inappropriate prescribing of antibiotics, in order
to reduce unnecessary patient and community antibiotic-
related harms.
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Table 3. Site and assessment of appropriateness for both treatment and prophylactic antibiotic regimens
Site Appropriate, n (%) Inappropriate, n (%) Not assessed, n (%)
Treatment
abdominal 40/60 (66.7) 16/60 (26.7) 4/60 (6.7)
CNS 4/6 (66.7) 2/6 (33.3) 0/6 (0)
dental 9/26 (34.6) 16/26 (61.5) 1/26 (3.8)
ear/nose/throat 44/105 (41.9) 58/105 (55.2) 3/105 (2.9)
gynaecological 23/32 (71.9) 7/32 (21.9) 2/32 (6.2)
orthopaedic 5/9 (55.6) 2/9 (22.2) 2/9 (22.2)
respiratory 106/160 (66.3) 52/160 (32.5) 2/160 (1.3)
unknown source 22/36 (61.1) 11/36 (30.6) 3/36 (8.3)
skin 150/209 (71.8) 54/209 (25.8) 5/209 (2.4)
urinary 119/159 (74.8) 35/159 (22.0) 5/159 (3.1)
other 19/41 (46.3) 18/41 (43.9) 4/41 (9.8)
Prophylaxis
bite prophylaxis 18/23 (78.3) 5/23 (21.7) 0/23 (0)
surgical prophylaxis 5/9 (55.6) 3/9 (33.3) 1/9 (11.1)
wound prophylaxis 65/118 (55.1) 45/118 (38.1) 8/118 (6.8)
other prophylaxis 11/21 (52.4) 9/21 (42.9) 1/21 (4.8)
Unknown indication 0/5 (0) 0/5 (0) 5/5 (100)
Appropriate antibiotics in the emergency department JAC
519
D
ow
nloaded from
 https://academ
ic.oup.com
/jac/article-abstract/74/2/515/5184551 by Bond U
niversity user on 20 July 2020
Funding
This work was supported by a grant from the Emergency Medicine
Foundation (grant number EMTR-110R27-2017-DENNY) and a
Queensland Health Junior Doctor Research Fellowship (to K. J. D.).
Transparency declarations
None to declare.
Supplementary data
Tables S1 and S2 appear as Supplementary data at JAC Online.
References
1 Sherwin R, Winters ME, Vilke GM et al. Does early and appropriate antibiotic
administration improve mortality in Emergency Department patients with
severe sepsis or septic shock? J Emerg Med 2017; 53: 588–95.
2 Tamma PD, Avdic E, Li DX et al. Association of adverse events with antibiot-
ic use in hospitalized patients. JAMA Intern Med 2017; 177: 1308–15.
3 Denny KJ, Cotta MO, Parker SL et al. The use and risks of antibiotics in critic-
ally ill patients. Expert Opin Drug Saf 2016; 15: 667–78.
4 May L, Cosgrove S, L’Archeveque M et al. A call to action for antimicrobial
stewardship in the emergency department: approaches and strategies. Ann
Emerg Med 2013; 62: 69–77.e2.
5 May L, Gudger G, Armstrong P et al. Multisite exploration of clinical decision
making for antibiotic use by emergency medicine providers using quantita-
tive and qualitative methods. Infect Control Hosp Epidemiol 2014; 35:
1114–25.
6 Losier M, Ramsey TD, Wilby KJ et al. A systematic review of antimicrobial
stewardship interventions in the Emergency Department. Ann Pharmacother
2017; 51: 774–90.
7 von Elm E, Altman DG, Egger M et al. The Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE) Statement: guidelines for
reporting observational studies. Int J Surg 2014; 12: 1495–9.
8 Levy MM, Fink MP, Marshall JC et al. 2001 SCCM/ESICM/ACCP/ATS/SIS
International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250–6.
9 Singer M, Deutschman CS, Seymour CW et al. The third international consen-
sus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315: 801–10.
10 Kawasaki T. Update on pediatric sepsis: a review. J Intensive Care 2017; 5: 47.
11 Therapeutic Guidelines Limited. eTG Complete. 2015. https://tgldcdp.tg.
org.au/etgcomplete.
12 National Centre for Antimicrobial Stewardship and Australian
Commission on Safety and Quality in Health Care. Antimicrobial Prescribing
Practice in Australian Hospitals: Results of the 2015 National Antimicrobial
Prescribing Survey. Sydney: Australian Commission on Safety and Quality in
Health Care, 2016.
13 James R, Upjohn L, Cotta M et al. Measuring antimicrobial prescribing
quality in Australian hospitals: development and evaluation of a national anti-
microbial prescribing survey tool. J Antimicrob Chemother 2015; 70: 1912–8.
14 Turnidge JD, Thursky K, Chen CS et al. Antimicrobial use in Australian hos-
pitals: how much and how appropriate? Med J Aust 2016; 205: S16–20.
15 de Groot B, Ansems A, Gerling DH et al. The association between time to
antibiotics and relevant clinical outcomes in emergency department patients
with various stages of sepsis: a prospective multi-center study. Crit Care 2015;
19: 194.
16 Vilella AL, Seifert CF. Timing and appropriateness of initial antibiotic
therapy in newly presenting septic patients. Am J Emerg Med 2014; 32:
7–13.
17 Yokota PK, Marra AR, Martino MD et al. Impact of appropriate antimicro-
bial therapy for patients with severe sepsis and septic shock–a quality im-
provement study. PLoS One 2014; 9: e104475.
18 Paul M, Shani V, Muchtar E et al. Systematic review and meta-analysis of
the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob
Agents Chemother 2010; 54: 4851–63.
19 Ewig S, Schlochtermeier M, Go¨ke N et al. Applying sputum as a diagnostic
tool in pneumonia: limited yield, minimal impact on treatment decisions.
Chest 2002; 121: 1486–92.
20 Chakraborti C, Le C, Yanofsky A. Sensitivity of superficial cultures in lower
extremity wounds. J Hosp Med 2010; 5: 415–20.
21 de Prost N, Razazi K, Brun-Buisson C. Unrevealing culture-negative severe
sepsis. Crit Care 2013; 17: 1001.
22 Mountain D, Bailey PM, O’Brien D et al. Blood cultures ordered in the adult
emergency department are rarely useful. Eur J Emerg Med 2006; 13: 76–9.
23 Long B, Koyfman A. Best clinical practice: blood culture utility in the
Emergency Department. J Emerg Med 2016; 51: 529–39.
24 Hall KK, Lyman JA. Updated review of blood culture contamination. Clin
Microbiol Rev 2006; 19: 788–802.
25 Shah T, Sterk E, Rech MA. Emergency department sepsis screening tool
decreases time to antibiotics in patients with sepsis. Am J Emerg Med 2018;
36: 1745–8.
26 Kumar A, Roberts D, Wood KE et al. Duration of hypotension before initi-
ation of effective antimicrobial therapy is the critical determinant of survival
in human septic shock. Crit Care Med 2006; 34: 1589–96.
27 Ferrer R, Martin-Loeches I, Phillips G et al. Empiric antibiotic treatment
reduces mortality in severe sepsis and septic shock from the first hour: results
from a guideline-based performance improvement program. Crit Care Med
2014; 42: 1749–55.
28 Gaieski DF, Mikkelsen ME, Band RA et al. Impact of time to antibiotics on
survival in patients with severe sepsis or septic shock in whom early goal-
directed therapy was initiated in the emergency department. Crit Care Med
2010; 38: 1045–53.
29 Venekamp RP, Sanders S, Glasziou PP et al. Antibiotics for acute otitis
media in children. Cochrane Database Syst Rev 2013; issue 1: CD000219.
30 Shabanzadeh DM, Wille-Jorgensen P. Antibiotics for uncomplicated diver-
ticulitis. Cochrane Database Syst Rev 2012; issue 11: CD009092.
31 Smith SM, Fahey T, Smucny J et al. Antibiotics for acute bronchitis.
Cochrane Database Syst Rev 2017; issue 6: CD000245.
32 Medeiros I, Saconato H. Antibiotic prophylaxis for mammalian bites.
Cochrane Database Syst Rev 2001; issue 2: CD001738.
33 Zehtabchi S. The role of antibiotic prophylaxis for prevention of infection
in patients with simple hand lacerations. Ann Emerg Med 2007; 49: 682–9.e1.
34 O’Brien AP, Rawlins MD, Ingram PR. Appropriateness and determinants of
antibiotic prescribing in an Australian emergency department. Emerg Med
Australas 2015; 27: 83–4.
35 Trinh TD, Klinker KP. Antimicrobial stewardship in the Emergency
Department. Infect Dis Ther 2015; 4: 39–50.
36 Finkelsztein EJ, Jones DS, Ma KC et al. Comparison of qSOFA and SIRS for
predicting adverse outcomes of patients with suspicion of sepsis outside the
intensive care unit. Crit Care 2017; 21: 73.
Denny et al.
520
D
ow
nloaded from
 https://academ
ic.oup.com
/jac/article-abstract/74/2/515/5184551 by Bond U
niversity user on 20 July 2020
